Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats
PLOS ONE · 09.01.2025 · 20 (1) · e0314029
DOI: 10.1371/journal.pone.0314029 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 09.01.2025. Verfasst von Cheng Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaan'xi, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Renal Insufficiency, Chronic, Curcumin, Nephrectomy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of the People’s Republic of China, Jiangxi Traditional Chinese Medicine Science and Technology Plan Project, Jiangxi Provincial Health Commission Science and Technology Program.
Abstract (Originalsprache)
Increasing evidence suggests that dysbiosis of gut microbiota exacerbates chronic kidney disease (CKD) progression. Curcumin (CUR) has been reported to alleviate renal fibrosis in animal models of CKD. However, the relationship between CUR and gut microbiome in CKD remains unclear. This study aims to investigate the potential anti-renal fibrosis effects of CUR from the gut microbiota perspective. A 5/6 nephrectomy (5/6Nx) rat model was used to explore the therapeutic effect of CUR on renal fibrosis. Tight junction protein expression levels were measured to assess intestinal barrier function. 16S rRNA sequencing was employed to evaluate changes in gut microbiota composition, and metabolomics was utilized to detect alterations in plasma metabolites. The administration of CUR significantly ameliorated renal fibrosis and inhibited inflammation in 5/6Nx rats. Additionally, CUR markedly improved the expression of tight junction proteins and local colon inflammation. CUR also positively reconstructed gut microbiota, significantly increasing the abundance of beneficial bacteria, such as Lachnospiraceae_NK4A136_group , Eubacterium_siraeum_group , and Muribaculaceae was significantly increased. Metabolomics revealed that CUR reduced uremic retention solutes and elevated Vitamin D and short-chain fatty acids (SCFAs). Spearman correlation analysis indicated that gut genera enriched by CUR were positively correlated with Vitamin D and SCFA and negatively correlated with chronic renal injury biomarkers. Mechanistically, we found inhibition of the LPS/TLR4/NF-κB and TGF-β1/Smads pathway in CUR-treated rats. Our study indicates that CUR has the potential to modulate gut microbiota composition, and that this modulation may contribute to the anti-fibrosis effects of CUR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaan'xi, China.
- Institute of Organ Transplantation, Xi'an Jiaotong University, Xi'an, Shaan'xi, China.
- Department of Nephrology, Jiujiang University Affiliated Hospital, Jiu'jiang, Jiang'xi, China.
- School of Clinical Medical, Jiujiang University, Jiu'jiang, Jiang'xi, China.
- Department of Pathology, Jiujiang University Affiliated Hospital, Jiu'jiang, Jiang'xi, China.
- Department of Nephrology, Xi'an Jiaotong University, Xi'an, Shaan'xi, China.
ORCID-Profile: PuXun Tian
Förderung
- National Natural Science Foundation of the People’s Republic of China
- Jiangxi Traditional Chinese Medicine Science and Technology Plan Project
- Jiangxi Provincial Health Commission Science and Technology Program
- Science and Technology Research Project of Jiangxi Provincial Department of Education
- Beijing Medical and Health Foundation
- Beijing Medical Award Foundation
Zitieren
APA
Li, C., Chen, X., Yao, J., Zha, W., Li, M., Shen, J., Jiang, H., & Tian, P. (2025). Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats. PLOS ONE, 20(1), e0314029. https://doi.org/10.1371/journal.pone.0314029
Vancouver
Li C, Chen X, Yao J, Zha W, Li M, Shen J, et al. Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats. PLOS ONE. 2025;20(1):e0314029. doi:10.1371/journal.pone.0314029
BibTeX
@article{Li2025,
author = {Li, Cheng and Chen, Xulong and Yao, Jingchun and Zha, Weiwei and Li, Meiren and Shen, Jiangwen and Jiang, Hongli and Tian, PuXun},
title = {Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {1},
pages = {e0314029},
doi = {10.1371/journal.pone.0314029}
}
EUVIMED